A 2015 Cochrane database assessment identified insufficient evidence to justify the use of G. lucidum as a first-line cancer therapy.[5][six] It said that G. lucidum may have "gain in its place adjunct to standard treatment method in consideration of its likely of enhancing tumour reaction and stimulating host immunity. Before https://andrebvygl.livebloggs.com/38773433/5-tips-about-brain-health-supplements-you-can-use-today